Position in ALNY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$453,050
-$59,467 QoQ
Shares Held
1,505
-2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#492
of 784 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fulton Bank, N.A. holds $5,566,847 across 7 Biotechnology names. ALNY ranks #6 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
17,286 | $1,959,540 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,081 | $1,297,586 | |
| 3 | TECH |
BIO-TECHNE Corp
|
8,152 | $575,938 | |
| 4 | INSM |
INSMED Inc
|
5,348 | $570,203 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
987 | $490,272 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,505 | $453,050 | |
| 7 | QURE |
uniQure N.V.
|
4,782 | $220,258 |
All Filings in ALNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $453,050 | 1,505 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $512,517 | 1,549 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $568,639 | 1,430 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $704,064 | 1,544 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $463,373 | 1,421 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $371,277 | 1,375 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $316,021 | 1,343 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $286,580 | 1,042 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $247,374 | 1,018 | Shares | Sole | 2024-07-09 | |
| No filing history on record for this holder in this stock. | ||||||